Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Additional Information (Details)

v3.22.2
Summary of Significant Accounting Policies - Additional Information (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 22, 2021
USD ($)
$ / shares
shares
Oct. 21, 2021
shares
May 31, 2022
USD ($)
plan
shares
May 31, 2021
USD ($)
May 31, 2022
USD ($)
plan
shares
May 31, 2021
USD ($)
Aug. 31, 2020
segment
Oct. 19, 2021
shares
Sep. 01, 2021
USD ($)
Aug. 31, 2021
USD ($)
shares
Dec. 31, 2020
Jan. 01, 2020
Concentration Risk [Line Items]                        
Contract with customer, term         12 months              
Contract with customer, cancellation period         30 days              
Unbilled accounts receivable     $ 3,470,000   $ 3,470,000         $ 2,741,000    
Number of reportable segments | segment             1          
Cash, uninsured amount     720,000   720,000              
Capitalized computer software, additions     0 $ 0 0              
Research and development expense     1,050,000.00 1,000,000 5,000,000 $ 2,700,000            
Operating lease, liability     8,328,000   8,328,000              
Impaired asset expense     4,004,000 0 4,004,000 0            
Workers' compensation, claim responsibility per occurrence     500,000   500,000              
Workers' compensation asset, current     0   0         155,000    
Workers' compensation asset, noncurrent     0   0         386,000    
Workers' compensation liability, current     663,000   663,000         663,000    
Workers' compensation liability, noncurrent     1,351,000   1,351,000         $ 1,646,000    
Disposal group, including discontinued operation, workers' compensation liability, current     1,300,000   1,300,000              
Disposal group, including discontinued operation, workers' compensation liability, noncurrent     3,100,000   3,100,000              
Disposal group, including discontinued operation, workers' compensation asset, current     0   0              
Disposal group, including discontinued operation, workers' compensation asset, noncurrent     0   0              
Advertising expense     $ 400,000 $ 400,000 $ 1,400,000 1,300,000            
Number of stock-based compensation plans | plan     1   1              
Class of warrant or right, outstanding (in shares) | shares     22,440,225   22,440,225         9,592,085    
Common stock, shares, transferred (in shares) | shares   15,000                    
Temporary equity, carrying amount, attributable to parent     $ 116,725,000   $ 116,725,000         $ 0    
Remeasurement of IHC temporary equity $ 13,000,000   160,000   13,431,000              
Deferred offering costs – SPACs (See Note 5)     $ 0   0         48,261,000    
SPAC related offering costs paid         $ 3,663,000 $ 611,000            
IHC                        
Concentration Risk [Line Items]                        
Deferred offering costs – SPACs (See Note 5) $ 9,500,000                 $ 9,800,000    
Accounting Standards Update 2018-11                        
Concentration Risk [Line Items]                        
Operating lease, liability                 $ 7,700,000      
IHC                        
Concentration Risk [Line Items]                        
Variable interest entity, qualitative or quantitative information, ownership percentage         15.00%              
Common stock, shares, owned (in shares) | shares 2,110,000 2,125,000 2,110,000   2,110,000              
Remeasurement of IHC temporary equity         $ 38,000,000              
SPAC related offering costs paid $ 3,500,000       $ 3,500,000              
IPO | IHC                        
Concentration Risk [Line Items]                        
Sale of stock, number of shares issued in transaction (in shares) | shares         11,500,000              
Proceeds from initial public offering of IHC 115,000,000                      
Assets held-in-trust $ 1,725,000   $ 1,700,000   $ 1,700,000              
Sale of stock, price per share (in dollars per share) | $ / shares $ 10.00                      
Sale of stock, number of common shares issued per unit (in shares) | shares 1             1        
Sale of stock, number of warrants issued per unit (in shares) | shares 1                      
Class of warrant or right, number of securities called by each warrant or right (in shares) | shares 1             1        
Exercise price of warrants (in dollars per share) | $ / shares $ 11.50                      
Business combination, initial business combination consummation period 12 months                      
Redeemable noncontrolling interest, equity, common, redemption percentage 100.00%                      
IPO | IHC | Placement Warrants                        
Concentration Risk [Line Items]                        
Exercise price of warrants (in dollars per share) | $ / shares $ 11.50                      
Class of warrant or right, outstanding (in shares) | shares 4,639,102                      
Sale of warrants, price per share (in dollars per share) | $ / shares $ 1.00                      
Aggregate purchase price $ 4,639,102                      
Measurement Input, Discount Rate                        
Concentration Risk [Line Items]                        
Note receivable, measurement input             0.15       0.15 0.10
Minimum                        
Concentration Risk [Line Items]                        
Capitalized software development, useful life         3 years              
Maximum                        
Concentration Risk [Line Items]                        
Capitalized software development, useful life         5 years              
Five Clients | Customer Concentration Risk | Accounts Receivable                        
Concentration Risk [Line Items]                        
Concentration risk, percentage         99.00%              
One Client | Customer Concentration Risk | Revenue from Contract with Customer Benchmark                        
Concentration Risk [Line Items]                        
Concentration risk, percentage       10.00%                
Two Clients | Customer Concentration Risk | Accounts Receivable                        
Concentration Risk [Line Items]                        
Concentration risk, percentage           92.00%